Ethanol → 1-{6-[(6-Ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea
Reaction equation
[N:1]1([CH2:7][CH2:8][NH:9][C:10]([NH:12][C:13]2[S:14][C:15]3[CH:21]=[C:20]([SH:22])[CH:19]=[CH:18][C:16]=3[N:17]=2)=[O:11])[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.C(O)C.SCC(C(CS)O)O.Cl[C:35]1[N:39]2[N:40]=[C:41]([O:44][CH2:45][CH3:46])[CH:42]=[CH:43][C:38]2=[N:37][N:36]=1>O.P([O-])(O)(O)=O.[K+]>[CH2:45]([O:44][C:41]1[CH:42]=[CH:43][C:38]2[N:39]([C:35]([S:22][C:20]3[CH:19]=[CH:18][C:16]4[N:17]=[C:13]([NH:12][C:10]([NH:9][CH2:8][CH2:7][N:1]5[CH2:2][CH2:3][O:4][CH2:5][CH2:6]5)=[O:11])[S:14][C:15]=4[CH:21]=3)=[N:36][N:37]=2)[N:40]=1)[CH3:46]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
The 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea was prepared according to the method described in Example 17a, but using 613 mg of 1-[2-(morpholin-4-yl)ethyl]-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea, 20 cm3 of degassed ethanol, 7 mg of potassium dihydrogen phosphate in 0.2 cm3 of water, 699 mg of DL-dithiothreitol and 300 mg of 3-chloro-6-ethoxy[1,2,4]triazolo[4,3-b]pyridazine. 354 mg of 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea are thus obtained in the form of a white powder, the characteristics of which are as follows:
Workup
- customThe 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea was prepared
Sources & evidence
- ORD record
- ord-f60aa43616f44124a61ea2f015acbe2a
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08546393B2
Reaction notes
Loading…